Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi Center, Open Label Study to Evaluate the Influence of Pioglitazone Treatment Over 6 Months on Metabolic Control in Type II Diabetic Patients Previously Treated With Insulin

NCT00576784 is registered in ClinicalTrials.gov with IKFE Institute for Clinical Research and Development as lead sponsor.

NCT NCT00576784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00576784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi Center, Open Label Study to Evaluate the Influence of Pioglitazone Treatment Over 6 Months on Metabolic Control in Type II Diabetic Patients Previously Treated With Insulin
Lead sponsor
IKFE Institute for Clinical Research and Development
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2005
Completion date
April 30, 2007
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, type 2 diabetes mellitus